Fundraising FoxRxMP Therapeutics
Miami, US · Founded 2017 · 1 known investors
Find your way into RxMP Therapeutics
Sign up to see every warm intro you have to RxMP Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RxMP Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RxMP Therapeutics develops systemically-delivered hemostatic agents based on red cell-derived microparticles, intended to stop or prevent excessive bleeding from trauma, surgery, and bleeding disorders. The technology aims to improve healthcare outcomes and reduce the need for transfused blood products.
Founders & leadership
RxMP Therapeutics was founded in 2017 by Rifat Pamukcu.
JW
Jy WencheNamed on SEC filing
Board
SV
Sue VanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2021
▶$1MraisedApr 2021 · 39 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2021 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sue VanDirector
- Rifat PamukcuExecutive Officer, Director, Promoter
- Jy WencheExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $1M
- Minimum investment
- $10K
- First sale
- Mar 2021
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does RxMP Therapeutics do?
- RxMP Therapeutics develops systemically-delivered hemostatic agents based on red cell-derived microparticles, intended to stop or prevent excessive bleeding from trauma, surgery, and bleeding disorders. The technology aims to improve healthcare outcomes and reduce the need for transfused blood products.
- Who founded RxMP Therapeutics?
- RxMP Therapeutics was founded by Rifat Pamukcu in 2017.
- Who are RxMP Therapeutics's investors?
- RxMP Therapeutics's investors include Florida Technology Seed Capital Fund.
- How much funding has RxMP Therapeutics raised?
- RxMP Therapeutics has disclosed $1M raised across 1 round.
- Where is RxMP Therapeutics headquartered?
- RxMP Therapeutics is headquartered in Miami, US.